Teva Pharmaceutical Industries Ltd (TEVA) stock
TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30113% above fair value
$43.24+0.84 (+1.98%)
Close on Nov 11, 2026Market cap $50.39BP/E 72.1Yield –
Teva Pharmaceutical Industries statistics
96 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Jan 11, 2027 (estimated, before the open)
- Last ex-dividend date
- Nov 27, 2017
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/OCF Ratio
- 26.80
- 12.93
Enterprise valuationIndustry
- EV / Sales
- 3.67
- 2.60
- EV / EBIT
- 32.26
- 18.72
- EV / FCF
- 38.36
- 22.07
Share statisticsIndustry
- Shares Change (YoY)
- 2.03%
- 10.9%
- Float
- 1.16B
- 49M
- Shares Held by Insiders
- 0.43%
- 12.1%
Short sellingIndustry
- Short Interest
- 28M
- –
- Short Interest Change
- -1.18%
- -0.76%
- Short % of Float
- 2.39%
- 9.06%
- Short % of Shares Outstanding
- 2.38%
- 6.30%
- Days to Cover
- 5.30
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $44.31
- –
- 52-Week Low
- $24.01
- –
- 20-Day Moving Average
- $41.44
- –
- 50-Day Moving Average
- $40.03
- –
- 200-Day Moving Average
- $35.05
- –
- Average True Range (14)
- $1.22
- –
- Price Change (1 Week)
- 4.48%
- 1.51%
- Price Change (1 Month)
- 7.20%
- -2.37%
- Price Change (3 Months)
- 18.7%
- -21.1%
- Price Change (6 Months)
- 23.6%
- -22.8%
- Price Change (YTD)
- 39.9%
- -22.6%
- Price Change (1 Year)
- 73.7%
- -21.0%
- Price Change (3 Years)
- 394.9%
- -24.8%
- Price Change (5 Years)
- 359.0%
- -76.9%
- Price Change (10 Years)
- 7.38%
- -63.2%
- Average Volume (10 Days)
- 9M
- –
- Average Volume (20 Days)
- 7M
- –
- Average Volume (90 Days)
- 6M
- –
- Relative Volume
- 1.57
- 0.80
- Relative Strength Index (14)
- 65.7
- 44.7
- Volatility (1 Year)
- 33.7%
- 80.2%
- Beta (5 Years)
- 0.98
- 1.07
MarginsIndustry
- Pretax Margin
- 5.02%
- -11.8%
- EBITDA Margin
- 18.4%
- -27.7%
- FCF Margin
- 9.56%
- -8.85%
Returns on capitalIndustry
- Return on Equity (ROE)
- 9.68%
- -51.3%
- Return on Assets (ROA)
- 1.77%
- -40.7%
- Return on Invested Capital (ROIC)
- 23.0%
- -32.9%
- Return on Capital Employed (ROCE)
- 6.62%
- -38.1%
Financial positionIndustry
- Current Ratio
- 0.88
- 3.31
- Quick Ratio
- 0.46
- 2.41
- Debt / Equity
- 0.58
- 0.50
- Debt / EBITDA
- 1.74
- 3.15
- Debt / FCF
- 3.34
- 4.68
- Net Debt / EBITDA
- 0.33
- 1.97
GrowthIndustry
- Revenue Growth (YoY)
- -15.2%
- 7.26%
- FCF Growth (YoY)
- 51.5%
- 7.48%
- Revenue Growth (3Y CAGR)
- 4.96%
- 2.25%
- Revenue Growth (5Y CAGR)
- 0.71%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.35
- 0.40
- Inventory Turnover
- 2.45
- 2.73
- Revenue Per Employee
- $415.43K
- $429.38K
- Profits Per Employee
- $20.80K
- -$683.67K
- Employee Count
- 33,950
- 75
- WACC
- 9.54%
- 10.0%
Income statement (TTM)Industry
- Pretax Income
- $708.00M
- -$13.23M
Balance sheetIndustry
- Net Cash (Debt)
- -$845.00M
- $16.98M
- Net Cash Per Share
- -$0.73
- $0.72
- Equity (Book Value)
- $7.75B
- $52.68M
- Book Value Per Share
- $6.65
- $1.50
- Tangible Book Value
- -$11.53B
- $26.74M
- Working Capital
- -$1.89B
- $78.52M
Cash flow (TTM)Industry
- Capital Expenditures
- -$550.00M
- -$944.00K
- FCF Per Share
- $1.16
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- 1.39%
- -21.0%
- FCF Yield
- 2.65%
- -9.44%
Taxes and interestIndustry
- Income Tax
- $12.00M
- $74.00K
- Effective Tax Rate
- 1.69%
- 20.9%
Scores and fair valueIndustry
- Graham Number
- $9.48
- $19.34
- Graham Upside
- -78.3%
- -46.3%
- Altman Z-Score
- 0.89
- 0.26
- Piotroski F-Score
- 8
- 4
- Beneish M-Score
- -2.37
- -2.62
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | TEVA | S&P 500 | Difference | TEVA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +5.2% | -2.4% | +7.6 pts | ||
| 3 months | +18.5% | -1.2% | +19.7 pts | ||
| Year to date | +38.5% | +12.3% | +26.3 pts | ||
| 1 year | +72.1% | +12.4% | +59.6 pts | ||
| 3 years | +398.2% | +78.8% | +319.3 pts | +70.8% | +21.4% |
| 5 years | +353.2% | +75.2% | +278.1 pts | +35.3% | +11.9% |
| 10 years | +11.0% | +311.1% | −300.1 pts | +1.0% | +15.2% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
28M TEVA shares were sold short on Oct 30, 2026, down 1.2% from the previous report, or 2.39% of the shares available to trade. At recent volumes it would take 5.3 days to buy them back. Over the last 20 sessions, 28.9% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 27,739,194 | -1.2% | 5,232,328 | 5.3 |
| Oct 15, 2026 | 28,070,513 | -6.0% | 7,162,026 | 3.9 |
| Sep 30, 2026 | 29,848,805 | -5.2% | 5,530,389 | 5.4 |
| Sep 15, 2026 | 31,478,314 | +11467.5% | 1,150,992 | 27.4 |
| Aug 31, 2026 | 37,614,253 | +5.4% | 4,877,029 | 7.7 |
| Aug 14, 2026 | 35,670,864 | +3.9% | 5,379,181 | 6.6 |
| Jul 31, 2026 | 34,320,980 | +4.8% | 5,976,563 | 5.7 |
| Jul 15, 2026 | 32,741,011 | +2.2% | 5,031,824 | 6.5 |
| Jun 30, 2026 | 32,029,657 | -4.0% | 6,283,326 | 5.1 |
| Jun 15, 2026 | 33,346,891 | -1.5% | 6,149,216 | 5.4 |
| May 29, 2026 | 33,869,008 | +27.1% | 5,646,510 | 6.0 |
| May 15, 2026 | 26,651,458 | -14.4% | 6,682,365 | 4.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?